Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sm pharmaceuticals sdn. bhd. - tetanus toxoid -

Namibia - englanti - Namibia Medicines Regulatory Council

serum institute of india ltd - adsorbed tetanus toxoid - injection - each single 0.5 ml human dose contains adsorbed tetanus toxoid ? 5 lf (? 40 iu)

Kanada - englanti - Health Canada

galderma canada inc - clobetasol propionate - shampoo - 0.05% - clobetasol propionate 0.05% - anti-inflammatory agents

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - malathion 1%{relative} - shampoo - 1% w/v - active: malathion 1%{relative} excipient: brilliant blue fcf citric acid monohydrate cocamide diolamine citrozone purified water sodium benzoate sodium chloride sodium laurilsulfate spike lavender oil tartrazine

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - clobetasol propionate 0.5 mg/g;  ;  ;   - shampoo - 0.5 mg/g - active: clobetasol propionate 0.5 mg/g       excipient: citric acid monohydrate coco-betaine ethanol polyquaternium-10 purified water sodium citrate dihydrate sodium laureth sulfate - the topical treatment of moderate to severe scalp psoriasis.

Kanada - englanti - Health Canada

grifols therapeutics llc - tetanus immunoglobulin (human) - solution - 250unit - tetanus immunoglobulin (human) 250unit - serums

Yhdysvallat - englanti - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - ceanothus americanus leaf (unii: 25b1y14t8n) (ceanothus americanus leaf - unii:25b1y14t8n) - ceanothus americanus leaf 1 [hp_x] - chronic bronchitis condition listed above or as directed by the physician

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

sanofi pasteur - purified diphtheria toxoid ph. eur.; purified tetanus toxoid; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus; haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0.5 millilitre(s) - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

sanofi pasteur - purified tetanus toxoid; purified diphtheria toxoid ph. eur.; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-pertussis-poliomyelitis-tetanus

Australia - englanti - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; hypromellose; silicon dioxide; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.